A5083452344- Respiratory viral infections research
- Viral gastroenteritis research and epidemiology
- Antimicrobial Resistance in Staphylococcus
- Viral Infections and Immunology Research
- Congenital Diaphragmatic Hernia Studies
- Antifungal resistance and susceptibility
- Hepatitis Viruses Studies and Epidemiology
- Pneumonia and Respiratory Infections
- Animal Virus Infections Studies
- Respiratory Support and Mechanisms
- Bacterial Identification and Susceptibility Testing
- Syphilis Diagnosis and Treatment
- Complementary and Alternative Medicine Studies
- Reproductive tract infections research
- Antibiotic Use and Resistance
- Fungal Infections and Studies
- Emergency and Acute Care Studies
- Bacterial Infections and Vaccines
- Neutropenia and Cancer Infections
- Influenza Virus Research Studies
- Tracheal and airway disorders
Stavanger University Hospital
2011-2024
St Olav's University Hospital
2016
Østfold Hospital Trust
2016
Norwegian Institute of Public Health
2016
Oslo University Hospital
2016
Norwegian University of Science and Technology
2016
Revmatismesykehuset
1998
To evaluate risk factors for severe disease in children under 59 months of age hospitalized with respiratory syncytial virus (RSV) infection.We prospectively enrolled 1,096 cases laboratory confirmed RSV infection during three consecutive seasons 2015-2018. Potential were retrieved through patient questionnaires and linkage to national health registries. Need support (invasive ventilation, bi-level positive airway pressure, or continuous pressure), length stay exceeding 72 h used as measures...
Objective There is conflicting evidence whether subtypes of Respiratory syncytial virus have different seasonality or are differentially associated with clinical severity. We aimed to explore the associations between disease severity and RSV RSV-A RSV-B describe circulation pattern by season age. Methods Active prospective hospital surveillance for in children <59 months age was conducted during 2015–2018. All febrile 12–59 were enrolled, whereas <12 eligible if presenting fever...
Background: In Norway, the epidemiological situation of candidemia is followed closely. We have previously demonstrated highest incidence in elderly >65 years age. However, knowledge other aspects this infection lacking.Objective: The aim nationwide, retrospective study was to examine risk factors, therapeutic practice and outcome adult patients according age.Methods: retrieved data from medical records who developed Norway between 1 January 2008 31 December 2012. Data were analyzed age,...
Background: Norway introduced routine rotavirus immunization for all children born on or after September 1, 2014. We estimated the healthcare burden of all-cause gastroenteritis and disease in <5 years old to establish prevaccine baseline support ongoing program. Methods: examined national registry data gastroenteritis-associated primary care consultations hospitalizations 2009–2013 deaths reported during 2000–2013. also established hospital surveillance from February 2014 through January...
Globally, rotavirus (RV) is the leading cause of acute gastroenteritis (AGE) in young children under 5 years age. Implementation RV vaccination expected to result fewer cases target population, but it unknown if this also results vaccine-induced virus strain replacement. Rotarix, a monovalent vaccine based on G1P[8] RV, was introduced Norway children's immunization program September 2014. The main aim study describe diversity circulating pre and post introduction investigate changes genotype...
To estimate age-specific incidence of medically attended respiratory syncytial virus (RSV) infections in hospitalised Norwegian children and describe disease epidemiology.Active prospective hospital surveillance for RSV <59 months age was conducted during 2015-2018. All febrile 12-59 were enrolled, whereas <12 enrolled based on symptoms regardless fever. Surveillance data linked to national registry the clinical burden RSV.Of 1096 (40%) infected with RSV. The highest rates found 1 month age,...
Use of rotavirus vaccines worldwide since 2006 has led to a significant impact on the burden disease. However, only third European countries have introduced vaccination in their immunization programs. In October 2014, was for Norwegian infants under strict age restrictions. Exclusive use monovalent vaccine (RV1) and high coverage from beginning enabled evaluation this during first 4 years after introduction.Prospective laboratory-based surveillance among children <5 hospitalized acute...
Background Norwegian health authorities do not recommend universal pediatric vaccination against seasonal influenza. We aimed to estimate the incidence of influenza by age and underlying medical conditions in hospitalized children aged &lt;18 years. Methods Active surveillance for years was implemented five hospitals during 2015–18. Children with respiratory symptoms and/or fever were prospectively enrolled tested Surveillance data linked registry national burden hospitals. Results In...